Mary Sue Sexton v. United States

832 F.2d 629, 266 U.S. App. D.C. 17, 1987 U.S. App. LEXIS 17402
CourtCourt of Appeals for the D.C. Circuit
DecidedNovember 6, 1987
Docket86-5677
StatusPublished
Cited by50 cases

This text of 832 F.2d 629 (Mary Sue Sexton v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the D.C. Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mary Sue Sexton v. United States, 832 F.2d 629, 266 U.S. App. D.C. 17, 1987 U.S. App. LEXIS 17402 (D.C. Cir. 1987).

Opinion

Opinion for the Court filed by Circuit Judge WILLIAMS.

WILLIAMS, Circuit Judge:

Plaintiffs Mary Sue and Talmon Sexton have suffered as severe a loss as a parent Can. Their son Dwayne died of leukemia at the age of six, after a three-year struggle against the disease. They and their son’s estate have brought suit against the United States under the Federal Tort Claims Act (“FTCA”), 28 U.S.C. § 2671 et seq. (1982), claiming medical malpractice by federal government doctors at a clinic run by the Oak Ridge Institute for Nuclear Studies (later Oak Ridge Associated Universities) (“Oak Ridge”), a corporation conducting research under contract with the federal government. The negligence alleged consists essentially of the doctors’ failure to provide chemotherapy as promptly and as continuously as they should have, and their use of radiation therapy techniques improperly exposing Dwayne to risks of infection. 1 Dwayne died on December 29, 1968, and the plaintiffs gave the government notice of their claim on June 14, 1983. The controlling statute of limitations, 28 U.S.C. § 2401(b) (1982), bars a claim of this sort unless it is presented “within two years after such claim accrues.” The district court found that the claim accrued on Dwayne's death and that accordingly the suit was barred. It granted summary judgment. Sexton v. United States, 644 F.Supp. 756 (D.D.C.1986). We affirm.

I

The relevant facts are neither complex nor seriously in dispute. In July 1965 the Sextons’ family doctor diagnosed Dwayne as having aplastic anemia and referred the family to the Oak Ridge clinic. Joint Appendix (“J.A.”) Exhibit (“Exh.”) 1 at 35. (Citations to exhibits are numbered as in the Joint Appendix.) When the Sextons admitted Dwayne to the clinic they were aware that it was funded by the Atomic Energy Commission and that it was an experimental research hospital. Id. at 45; Exh. 3 at 36-37. Both parents signed an admittance agreement which stated, in part, that “any treatments administered ... may be experimental.” Exh. 4 at 19.

After conducting several tests on Dwayne, the doctors at Oak Ridge rejected the earlier diagnosis and told the Sextons that Dwayne in fact had leukemia. Exh. 1 at 50-51. Independently of any discussion with the doctors, the Sextons believed at the time that the disease was fatal. As Mrs. Sexton later testified, “1 knew leukemia was fatal. I knew that myself.” Exh. 4 at 15; see also Exh. 1 at 61. That understanding appears to have been essentially correct. The only data in the record indicate that according to figures of the American Cancer Society, in the period 1965-69 the one-year survival rate for children under 15 with acute leukemia was 40 percent and the five-year survival rate was three percent. Exh. 4 at 207. None of Mrs. Sexton’s testimony would support a claim that the doctors ever gave her a picture of the prospects under conventional *631 treatment more gloomy than the reality. See, e.g., Exh. 1 at 68-69.

Over the several days following this news, the doctors discussed several alternative methods of treating the disease. They explained to the Sextons that chemotherapy, the “standard treatment,” would most probably offer Dwayne a lifespan of only three to five more years. They also described an experimental treatment called immunotherapy, which involved removing bone marrow from Dwayne, injecting the cells into a compatible donor, and re-injecting the cells into Dwayne. According to Mrs. Sexton, the doctors presented the experimental immunotherapy treatment as highly promising and a possible cure for leukemia. Id. at 58-61; Exh. 3 at 45-49. The doctors expressly told the Sextons that if they elected to try the immunotherapy, maintenance chemotherapy would be withheld in order to analyze the effects of the experimental treatment. Id. at 52; Exh. 1 at 78-79. They then took blood tests of both parents, and decided that Mrs. Sexton was the more compatible donor. The Sextons elected to try the experimental immu-notherapy. They signed a form consenting to the treatment, acknowledging awareness that it was experimental and carried risks for both mother and child. Exh. 4 at 20.

Before the doctors started the experimental immunotherapy treatment, they gave Dwayne 17 days of chemotherapy. Id. at 208. In late August 1965 they performed the immunotherapy procedure on Dwayne and Mrs. Sexton, apparently successfully: Dwayne was in remission by mid-September. Id. at 208. In November 1965, however, he suffered a relapse and was readmitted to Oak Ridge. Id. at 208. Although the doctors suggested that immu-notherapy be tried once again, with his father as the donor, the Sextons refused, fearing that Mr. Sexton might himself contract leukemia. Id. at 12; Exh. 1 at 119-20; Exh. 3 at 65-67. Dwayne was put on chemotherapy for the next three years. Exh. 4 at 205.

From late 1965 until late 1968, Dwayne underwent chemotherapy as an outpatient at Oak Ridge, alternating between remission and relapse at least four times. During this period, the Oak Ridge doctors forwarded Dwayne’s medical records to the Sextons’ family physician, Dr. Northrop, Exh. 1 at 107,129, and discussed Dwayne’s treatment and prognosis with him on several occasions. Id. at 129-30. In addition, Dr. Northrop sometimes administered chemotherapeutic drugs to Dwayne between outpatient visits to Oak Ridge. Id. at 129. During these visits Dwayne’s parents discussed the treatment with Dr. Northrop. Id. at 140-41. Mrs. Sexton also set out to educate herself about leukemia. During the 1965-68 period she read many magazine and newspaper articles about the disease and possible treatments, id. at 133; by mid-1966 she was aware that even a short delay in treatment could harm the chances of a leukemia patient. Id. at 184. 2

In November 1968 Dwayne suffered his final relapse and, now gravely ill, was admitted again to Oak Ridge. The physicians told his mother that Dwayne’s leukemia was no longer responding to the treatment. Id. at 157. They suggested three alternatives: blood transfusions, which might only prolong his life by a matter of days or weeks; experimental chemotherapy; or experimental total-body radiotherapy. Id. at 157. They recommended the latter, suggesting that it might bring about a total remission. Id. at 158. They told the Sextons, however, that infection was a serious risk and must be avoided. Id. at 171; Exh. 3 at 76. After their review of the hazards and potential benefits of each, Exh. 4 at 208, Mrs. Sexton agreed to try total-body radiation. Again she signed a form which described the risks and experimental nature of the treatment and noted that it was not usual, that it was unproven, and that “the consequences may be unpredictable.” Id. at 21.

Dwayne underwent total-body radiation therapy in the Medium Exposure Total

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jenkins v. Unity Health Care, Inc.
District of Columbia, 2022
Fusco v. Lanpher
District of Columbia, 2021
Abale Gnalega v. United States
District of Columbia, 2020
Johnson v. Paragon Systems, Inc.
District of Columbia, 2018
Johnson v. Paragon Sys., Inc.
305 F. Supp. 3d 139 (D.C. Circuit, 2018)
Bradley v. National Collegiate Athletic Association
249 F. Supp. 3d 149 (District of Columbia, 2017)
Miango v. Democratic Republic of Congo
243 F. Supp. 3d 113 (District of Columbia, 2017)
Warren v. Central Intelligence Agency
210 F. Supp. 3d 199 (District of Columbia, 2016)
Melvin v. United States Department of Veterans Affairs
70 F. Supp. 3d 350 (District of Columbia, 2014)
In Re: Navy Chaplaincy
69 F. Supp. 3d 249 (District of Columbia, 2014)
M.J. Ex Rel. Jarvis v. Georgetown University Medical Center
962 F. Supp. 2d 3 (District of Columbia, 2013)
Gable v. United States
931 F. Supp. 2d 143 (District of Columbia, 2013)
Hagan v. United States
District of Columbia, 2012
Olaniyi v. United States
District of Columbia, 2011
OLANIYI v. District of Columbia
763 F. Supp. 2d 70 (District of Columbia, 2011)
Henderson v. Alexander
District of Columbia, 2009
Santos Ex Rel. Beato v. United States
559 F.3d 189 (Third Circuit, 2009)
Santos v. United States
Third Circuit, 2009

Cite This Page — Counsel Stack

Bluebook (online)
832 F.2d 629, 266 U.S. App. D.C. 17, 1987 U.S. App. LEXIS 17402, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mary-sue-sexton-v-united-states-cadc-1987.